14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $116.30 $116.30 Thursday, 4th Jan 2024 HZNP stock ended at $116.30. During the day the stock fluctuated 0% from a day low at $116.30 to a day high of $116.30.
90 days $116.30 $116.30
52 weeks $90.61 $116.38

Historical Horizon Therapeutics Public Limited Company prices

Date Open High Low Close Volume
Oct 23, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 20, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 19, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 18, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 17, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 16, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 13, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 12, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 11, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 10, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 09, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 06, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 05, 2023 $116.34 $116.38 $116.26 $116.30 28 845 652
Oct 04, 2023 $116.23 $116.26 $116.20 $116.25 5 929 937
Oct 03, 2023 $116.23 $116.27 $116.18 $116.23 4 578 846
Oct 02, 2023 $115.80 $115.95 $115.70 $115.93 1 953 416
Sep 29, 2023 $115.75 $115.75 $115.66 $115.69 1 702 553
Sep 28, 2023 $115.77 $115.80 $115.66 $115.69 1 247 798
Sep 27, 2023 $115.74 $115.85 $115.70 $115.70 1 220 736
Sep 26, 2023 $115.66 $115.80 $115.62 $115.74 1 793 168
Sep 25, 2023 $115.61 $115.80 $115.55 $115.66 961 544
Sep 22, 2023 $115.56 $115.70 $115.51 $115.61 1 578 469
Sep 21, 2023 $115.65 $115.71 $115.50 $115.50 1 556 247
Sep 20, 2023 $115.49 $115.65 $115.44 $115.60 1 507 868
Sep 19, 2023 $115.40 $115.55 $115.38 $115.51 1 797 927
Click to get the best stock tips daily for free!

About Horizon Therapeutics Public Limited Company

Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-... HZNP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT